Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(11 sites)
United States
USC Norris Comprehensive Cancer Center, Los Angeles, California LA Cancer Network, Los Angeles, California Orlando Health, Orlando, Florida Moffitt Cancer Center, Tampa, Florida University Of Chicago Medical Center, Chicago, Illinois